IL114729A0 - Azaaliphatically bridged quinoxaline-3, 3-diones - Google Patents
Azaaliphatically bridged quinoxaline-3, 3-dionesInfo
- Publication number
- IL114729A0 IL114729A0 IL11472995A IL11472995A IL114729A0 IL 114729 A0 IL114729 A0 IL 114729A0 IL 11472995 A IL11472995 A IL 11472995A IL 11472995 A IL11472995 A IL 11472995A IL 114729 A0 IL114729 A0 IL 114729A0
- Authority
- IL
- Israel
- Prior art keywords
- azaaliphatically
- diones
- bridged quinoxaline
- quinoxaline
- bridged
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH236694 | 1994-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL114729A0 true IL114729A0 (en) | 1995-11-27 |
Family
ID=4232111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11472995A IL114729A0 (en) | 1994-07-27 | 1995-07-25 | Azaaliphatically bridged quinoxaline-3, 3-diones |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0705834A1 (en) |
| JP (1) | JPH0873465A (en) |
| KR (1) | KR960004346A (en) |
| CN (1) | CN1117493A (en) |
| AU (1) | AU2711695A (en) |
| BR (1) | BR9503458A (en) |
| CA (1) | CA2154624A1 (en) |
| FI (1) | FI953549A (en) |
| HU (1) | HUT73438A (en) |
| IL (1) | IL114729A0 (en) |
| NO (1) | NO952959L (en) |
| NZ (1) | NZ272639A (en) |
| ZA (1) | ZA956209B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063774A (en) * | 1996-12-16 | 2000-05-16 | Warner-Lambert Company | Tricyclic quinoxaline derivatives as neuroprotective agents |
| AU9651198A (en) | 1997-11-11 | 1999-05-31 | Ono Pharmaceutical Co. Ltd. | Fused pyrazine compounds |
| IN2012DN03448A (en) | 2009-10-26 | 2015-10-23 | Warner Chilcott Co Llc |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK715888D0 (en) * | 1988-12-22 | 1988-12-22 | Ferrosan As | QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE |
| DK716188D0 (en) * | 1988-12-22 | 1988-12-22 | Ferrosan As | QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE |
| KR0167346B1 (en) * | 1989-06-09 | 1999-01-15 | 로버트 에이. 아미테이지 | Heterocyclic amines having central nervous system activity |
| JPH05117276A (en) * | 1991-10-23 | 1993-05-14 | Sumitomo Pharmaceut Co Ltd | New tricyclic quinoxalinedione derivative |
| EP0647137B1 (en) * | 1992-06-22 | 2008-08-13 | The Regents Of The University Of California | Glycine receptor antagonists and the use thereof |
| DE69313866T2 (en) * | 1992-10-13 | 1998-03-05 | Warner Lambert Co | CHINOXAL DERIVATIVES AS EAA ANTAGONISTS |
| US5631373A (en) * | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
-
1995
- 1995-07-18 EP EP95810470A patent/EP0705834A1/en not_active Withdrawn
- 1995-07-20 AU AU27116/95A patent/AU2711695A/en not_active Abandoned
- 1995-07-24 FI FI953549A patent/FI953549A/en not_active Application Discontinuation
- 1995-07-25 IL IL11472995A patent/IL114729A0/en unknown
- 1995-07-25 NZ NZ272639A patent/NZ272639A/en unknown
- 1995-07-25 JP JP7189177A patent/JPH0873465A/en active Pending
- 1995-07-25 CA CA002154624A patent/CA2154624A1/en not_active Abandoned
- 1995-07-26 NO NO952959A patent/NO952959L/en unknown
- 1995-07-26 CN CN95108718A patent/CN1117493A/en active Pending
- 1995-07-26 ZA ZA956209A patent/ZA956209B/en unknown
- 1995-07-26 HU HU9502240A patent/HUT73438A/en unknown
- 1995-07-26 BR BR9503458A patent/BR9503458A/en not_active Application Discontinuation
- 1995-07-26 KR KR1019950022224A patent/KR960004346A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT73438A (en) | 1996-07-29 |
| FI953549A0 (en) | 1995-07-24 |
| ZA956209B (en) | 1996-01-29 |
| FI953549A (en) | 1996-01-28 |
| JPH0873465A (en) | 1996-03-19 |
| NO952959D0 (en) | 1995-07-26 |
| CN1117493A (en) | 1996-02-28 |
| AU2711695A (en) | 1996-02-08 |
| KR960004346A (en) | 1996-02-23 |
| CA2154624A1 (en) | 1996-01-28 |
| HU9502240D0 (en) | 1995-09-28 |
| NO952959L (en) | 1996-01-29 |
| EP0705834A1 (en) | 1996-04-10 |
| NZ272639A (en) | 1997-05-26 |
| BR9503458A (en) | 1996-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9711092B (en) | Novel compounds. | |
| ZA9710429B (en) | Broad-spectrumδ-endotoxins. | |
| DE59812367D1 (en) | 2-arylcyclopentan-1,3-dione | |
| HK1018216A1 (en) | New 19-nor-pregnene derivatives. | |
| AU2681895A (en) | 8-aryl-1,6-naphthyridin-5-ones | |
| PL328505A1 (en) | 2-heteroaroylcyclohexano-1,3-diones | |
| ZA978304B (en) | 3-alkyl-3-phenyl-piperidines. | |
| EP0664969A3 (en) | Skiboot. | |
| DE69723848D1 (en) | 3-descladinose-2,3-anhydroerythromycin-derivate | |
| ZA9711567B (en) | Compounds. | |
| ZA975861B (en) | Bromotiacumicin compounds. | |
| ZA97928B (en) | Novel heteroaryl-oxazolidinones. | |
| ZA97572B (en) | 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines. | |
| PL334473A1 (en) | Substituted 2-benzoylcyclohexano-1,3-diones | |
| EP0684299A3 (en) | Dihydrofarnesal. | |
| ZA974052B (en) | New benzothiazolinones. | |
| IL114729A0 (en) | Azaaliphatically bridged quinoxaline-3, 3-diones | |
| ZA971466B (en) | Endothelin-receptor-antagonists. | |
| GR3034943T3 (en) | Medrogestrone. | |
| EP0672364A3 (en) | Skiboot. | |
| ZA974056B (en) | New thiazolopyridines. | |
| EP0671133A3 (en) | Skiboot. | |
| ZA979404B (en) | Aspirinate compounds. | |
| PL336794A1 (en) | Substituted 2-benzoylcyclohexane-1,3-diones | |
| ZA971474B (en) | Endothelin-receptor-antagonists. |